CPIC 2026 | Alioth Special Session: Building an Innovative Collaboration Ecosystem for the Biopharmaceutical Supply Chain
May 29,2026
As China’s biopharmaceutical industry accelerates its global expansion in 2026, the internationalization of innovative medicines increasingly depends on breakthroughs in bioprocess technologies and supply chain security.
How can China’s biopharmaceutical supply chain evolve from “Made in China” to “Created in China”? Can China’s bioprocessing industry help define new global quality standards?
During the 1st China Pharmaceutical Innovation Conference (CPIC), Alioth will host a dedicated session titled “Building an Innovative Collaboration Ecosystem for the Biopharmaceutical Supply Chain” on July 22.
At the session, Alioth will officially unveil the latest achievements of its proprietary virus filtration membrane technology. Bringing together leaders from industry, investment, and regulatory sectors, the forum will feature in-depth discussions on process innovation, supply chain resilience, regulatory compliance, industrial collaboration, and capital empowerment, with the goal of building an integrated ecosystem that supports China’s innovative medicines in reaching global markets.
Driven by innovation, we break through global barriers. Connected through collaboration, we shape the future of the industry.
We sincerely invite you to join global industry leaders, scientists, and partners at CPIC to exchange ideas, foster collaboration, and explore the future of biopharmaceutical innovation together.
Session Agenda
14:00–17:30 | July 22, 2026
14:00–14:30 The Evolution of China’s Bioprocessing Industry and Its Global Opportunities
Dr. Ian Carmichael：Senior Vice President, Alioth
14:30–14:50 Global Launch of ALIOTH’s Proprietary Virus Filtration Membrane
Weijun Gu：Honorary President, China Pharmaceutical Association of Pharmaceutical Equipment (CPAPE)Director of the Expert Committee, CPAPE
14:50–15:20 Reshaping Global Value: Systematic Transformation and Supply Chain Resilience for China’s Innovative Drug Globalization
Dr. Qicong Hu：Managing Director & Partner, Boston Consulting Group (BCG)
15:20–15:40 Coffee Break
15:40–16:10 Advancing Innovation in Cell Culture Media in the Era of Globalization
Dr. Liang Zhao：Senior Vice President, BioEngine Scientific
16:10–16:40 Regulatory Perspectives on Process Changes in Biologics Manufacturing: Compliance Pathways and Risk Control
Dr. Xiao Qiu：Vice President, Shanghai Institute for Drug Control (SIDC)
16:40–17:30 Panel Discussion：How China’s Bioprocessing Industry Can Serve the Global Biopharmaceutical Market
- Investment Institutions
- Biopharmaceutical Companies
- Supply Chain Enterprises
More speakers to be announced.
Follow or Contact Us
Follow the TONACEA Official WeChat Account and scan the QR code to register. Stay updated with the latest conference news.
Public Account QR Code
Registration QR Code
Conference Service Hotline
© 2026 TONACEA (Shanghai) Technology Development Co., Ltd. All rights reserved. All rights reserved.
